The stock of niche financial software company Vertex ( VERX 4.13%) didn't get a very good start to the trading week at all.

Vertex Pharmaceuticals VRTX reported adjusted earnings of $4.80 per share for the third quarter of 2025, surpassing the Zacks ...

KING OF PRUSSIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results ...

Vertex stock dipped Tuesday on a mixed third-quarter report, with the lion's share of its sales beat coming from its older ...

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...

Vertex (NASDAQ: VERX) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table below ...

Thankfully, some companies can handle an inflationary environment and perform well throughout, while still registering the 12 ...

Investors want their money to grow in some shape, form, or fashion with every stock they buy. However, I understand that ...

The U.S. markets are now closed. Amid the backdrop of a struggling market today, the Nasdaq Composite (+0.46%) eked out a ...

Thinking about what to do with Vertex Pharmaceuticals stock? You are not alone. The biotech powerhouse has seen its shares ...

The stock's fall snapped a three-day winning streak.